The countdown is on! 🎉In just 4 weeks, we’ll be welcoming delegates to Bham for the SAHF 27th Annual Conference. Taking place on 26-27 November at the NCC, Bham, the two day conference brings together an exciting programme of lectures & masterclasses. sahf.org.uk/events

Retatrutide Once Weekly for Treatment of Obstructive Sleep Apnea resulted in significant improvements of AHI scores nejm.org/doi/abs/10.105…

GLP-1 receptor agonist initiation and risk of psychiatric hospitalisation and emergency department presentation in adults with schizophrenia and type 2 diabetes in the USA: an observational cohort study using electronic health records data
thelancet.com/journals/lanps…

Our paper on the effects of behavioural sleep intervention on Obesity @AbdTahrani @samiul_m @Feaz2011 @Nirantharakumar @UHBDiabetes onlinelibrary.wiley.com/doi/10.1111/ob…

Safety of glucose lowering therapy in first trimester of pregnancy. GLP -1 slight increase risk CV defect link.springer.com/article/10.100…

SURPASS CVOT sub analysis for retinopathy with Tirzepatide. No worsening when compared to Dulaglutide @EASDnews #EASD2026

Traditional EASD curry night in Milan #EASD2026 @kamleshkhunti @AmarPut @AliRacaniere @kamleshkhunti @rahmoh1

This is verified account of Kamlesh @kamleshkhunti please follow @AliRacaniere @m_alikaramat @AliaGilani @SouthAsianHF @rahmoh1 @ShivaniM_KC @AskDrShashank @banshisaboo @dramitaol @AmarPut @SouthAsianHF @purvi_chawla @sribellary spread the word @Azeem_Majeed @ClareHambling

Dear Friends
Unfortunately I didn't get my hacked twitter account back & have started a new account.

Please do follow me again🙏🏻

@parthaskar @ShivaniM_KC @mmamas1973 @WilmotEmma @EASDnews @ADA_DiabetesPro @DiabetologiaJnl @LDC_tweets @drpratikc @AmarPut @DanielJDrucker

HCP factors influence delivery of Obesity care @EASDnews #EASD2026

Addressing psychological barriers for obesity management. The 5 As…@EASDnews #EASD2026

SURMOUNT-MAINTAIN answers the important question of “What happens when you stop a Mounjaro?” Which every patient wants to know….if you stop completely you will gain weight @EASDnews #EASD2026

The challenges managing obesity in South Asian populations and strategies to mitigate risk of Sarcopenia @EASDnews #EASD2026 DASG symposium

📢 SAHF Poster Competition: Deadline 2 October!

There’s still time to submit your poster for the SAHF Poster Competition. Showcase your work at the SAHF Annual Conference and share your research with colleagues and delegates.

Submit by 2 October 2026.

Novo CagriSema shows superior weight loss to Tirzepatide novonordisk.com/news-and-media…

Great message from @AlexZverev on winning US open. Giving hope to millions of people with type 1 diabetes in countries without access to latest treatments @DiabetesUK @BT1DUK @IntDiabetesFed @Jazzsethi95 instagram.com/reel/DdP456yCB…

SURMONT 1 DXA study with Tirzepatide , 75% weight loss is fat mass and 25% lean mass which is comparable to placebo dom-pubs.onlinelibrary.wiley.com/doi/full/10.11…

Cultural competence in the NHS bmj.com/content/394/bm…

GLP-1 receptor agonists at the crossroads of metabolic and gut inflammation: Implications for people with type 2 diabetes and inflammatory bowel disease journals.sagepub.com/doi/10.1177/20…

📢 FREE registration is OPEN!

Join us 26–27 Nov for the 27th SAHF Annual Conference at NCC Birmingham.

Connect with colleagues & hear from experts in multimorbidity, diabetes, cardiovascular & obesity care.

Secure your free place 👇
sahf.typeform.com/conf26